Singular Bio

About:

Singular Bio is a privately held company developing single molecule detection technology.

Website: https://www.singularbio.com

Top Investors: Casdin Capital, Civilization Ventures

Description:

Singular Bio's technology provides single molecule analysis of a patient's DNA, giving exquisite sensitivity for detecting many common conditions. The company's mission is to expand access to fundamental healthcare information by making advanced genetic tests available to everyone.

Total Funding Amount:

$6.58M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Founders:

Hywel Jones

Number of Employees:

11-50

Last Funding Date:

2019-01-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai